Edwards Lifesciences Corporation Stock
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.20 USD | +5.70% |
|
+2.96% | -2.69% |
| 03:28pm | Leerink Adjusts Price Target on Edwards Lifesciences to $74 From $73 | MT |
| 01:54pm | Edwards Lifesciences Provides 2025 Guidance | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 41.4B 39.32B 36.57B 32.56B 58.27B 3,508B 64.33B 453B 168B 1,439B 155B 152B 6,217B | P/E ratio 2024 * |
30.4x | P/E ratio 2025 * | 28.1x |
|---|---|---|---|---|---|
| Enterprise value | 37.98B 36.06B 33.54B 29.87B 53.44B 3,217B 59B 415B 154B 1,320B 143B 140B 5,702B | EV / Sales 2024 * |
6.51x | EV / Sales 2025 * | 6.4x |
| Free-Float |
89.32% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Edwards Lifesciences Corporation
More recommendations
More press releases
More news
| 1 day | +5.70% | ||
| 1 week | +2.96% | ||
| Current month | +3.99% | ||
| 1 month | +11.63% | ||
| 3 months | +7.65% | ||
| 6 months | -15.11% | ||
| Current year | -2.69% |
1 week
69.35
74.68
1 month
64.8974.68
Current year
58.9396.12
1 year
58.9396.12
3 years
58.93131.73
5 years
51.51131.73
10 years
20.46131.73
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2023-05-10 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 2013-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 2019-01-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 60 | 2015-02-09 |
| Director/Board Member | 56 | 2023-05-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 42 M€ | +4.92% | - | |
| 2.34% | 20 M€ | +16.48% | - | |
| 1.17% | 23 M€ | +2.68% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +5.70% | +2.96% | +7.26% | -33.73% | 41.4B | ||
| -1.04% | +1.38% | +6.77% | -15.01% | 204B | ||
| +1.52% | +2.12% | +76.36% | +69.86% | 193B | ||
| -1.91% | -1.08% | +6.36% | -23.02% | 174B | ||
| +0.41% | +0.10% | +65.86% | +123.19% | 133B | ||
| +0.12% | +1.85% | -2.63% | -18.85% | 60.83B | ||
| -0.44% | -2.63% | -10.53% | -26.47% | 43.28B | ||
| +0.66% | +1.49% | +8.78% | -7.44% | 39.72B | ||
| +0.53% | +0.01% | +19.66% | - | 37.72B | ||
| -0.43% | -1.40% | +52.19% | -5.56% | 36.23B | ||
| Average | +0.40% | +0.74% | +23.01% | +7.00% | 96.39B | |
| Weighted average by Cap. | -0.03% | +1.29% | +29.75% | +20.14% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 5.83B 5.54B 5.15B 4.59B 8.21B 494B 9.06B 63.76B 23.7B 203B 21.91B 21.43B 876B | 5.92B 5.62B 5.23B 4.66B 8.33B 502B 9.2B 64.72B 24.05B 206B 22.24B 21.75B 889B |
| Net income | 1.39B 1.32B 1.23B 1.09B 1.95B 118B 2.16B 15.16B 5.64B 48.21B 5.21B 5.1B 208B | 1.48B 1.41B 1.31B 1.17B 2.09B 126B 2.31B 16.22B 6.03B 51.58B 5.58B 5.45B 223B |
| Net Debt | -3.43B -3.25B -3.03B -2.7B -4.82B -290B -5.32B -37.45B -13.92B -119B -12.87B -12.59B -515B | -3.51B -3.34B -3.1B -2.76B -4.94B -298B -5.46B -38.41B -14.27B -122B -13.2B -12.91B -528B |
More financial data
* Estimated data
Employees
19,800
Calendar
08:30am
- Investor Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-04 | 74.20 $ | +5.70% | 6,631,471 |
| 24-12-03 | 70.20 $ | -0.47% | 5,808,909 |
| 24-12-02 | 70.53 $ | -1.15% | 6,509,833 |
| 24-11-29 | 71.35 $ | -1.00% | 2,125,966 |
| 24-11-27 | 72.07 $ | +0.73% | 2,753,319 |
Delayed Quote Nyse, December 04, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
70.20USD
Average target price
76.81USD
Spread / Average Target
+9.41%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock